Descriptor English: | Interferon-gamma | ||||||
Descriptor Spanish: |
Interferón gamma
| ||||||
Descriptor Portuguese: | Interferon gama | ||||||
Descriptor French: | Interféron gamma | ||||||
Entry term(s): |
Immune Interferon Interferon Type II Interferon, Immune Interferon, Type II Interferon, gamma Type II Interferon gamma-Interferon |
||||||
Tree number(s): |
D12.644.276.374.440.893 D12.644.276.374.480.615.350 D12.776.467.374.440.893 D12.776.467.374.480.615.350 D23.529.374.440.893 D23.529.374.480.615.350 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007371 | ||||||
Scope note: | The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Pharm Action: |
Antiviral Agents |
||||||
Registry Number: | 82115-62-6 | ||||||
CAS Type 1 Name: | Interferon gamma (human lymphocyte protein moiety reduced) | ||||||
Previous Indexing: |
Interferons (1966-1982) |
||||||
Public MeSH Note: | 2009; see INTERFERON TYPE II 1984-2008, see INTERFERON, GAMMA 1983-1990 |
||||||
History Note: | 2009(1983); INTERFERON-GAMMA was INTERFERON, GAMMA 1983-1990 |
||||||
Related: |
Interferon-gamma Release Tests
MeSH | ||||||
DeCS ID: | 29484 | ||||||
Unique ID: | D007371 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1983/01/01 | ||||||
Date of Entry: | 1982/05/19 | ||||||
Revision Date: | 2015/06/22 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Interferon-gamma
- Preferred
Concept UI |
M0011490 |
Scope note | The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. |
Preferred term | Interferon-gamma |
Entry term(s) |
Immune Interferon Interferon Type II Interferon, Immune Interferon, Type II Interferon, gamma Type II Interferon gamma-Interferon |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey